Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 22, 2026
Why Is ADTRAN Holdings (ADTN) Stock Down -15.82% Today?

Why Is ADTRAN Holdings (ADTN) Stock Down -15.82% Today?

Key Takeaways

  • ADTRAN Holdings shares plunged approximately 15.82% on Wednesday, erasing the previous session's gains and more.
  • The sell-off was triggered by a preliminary Q2 2026 earnings miss, with revenue, operating margin, and EPS all coming in below prior guidance and analyst consensus.
  • CEO Tom Stanton cited a project delay from a single customer and elevated component and freight costs as the primary culprits.
  • Q3 2026 guidance also disappointed, with revenue projected at $275M–$295M and non-GAAP operating margin of just 1.5%–5.5%.
  • The stock extended a broader downtrend that has now seen ADTN shed more than 30% over the past three months.
  • Traders now look ahead to the full Q2 earnings release on August 3, 2026 and the subsequent conference call for further clarity on the path forward.

Opening Summary

Shares of ADTN, the parent company of Adtran, Inc. — a global provider of open, disaggregated networking and communications solutions serving service providers, enterprises, and government organizations — plummeted 15.82% in Wednesday's trading session. The stock was changing hands near $10.22 as of midday, a sharp decline from Tuesday's closing price of $12.14. The catalyst was unmistakable: the company issued a preliminary second-quarter 2026 update before the opening bell that revealed revenue, non-GAAP operating margin, and earnings per share all falling short of both internal forecasts and Wall Street expectations.

Preliminary Q2 Results Miss on Multiple Fronts

ADTRAN Holdings released preliminary unaudited results for the second quarter ended June 30, 2026, and the numbers painted a sobering picture. Preliminary U.S. GAAP revenue came in between $280.0 million and $282.0 million, missing the company's previously issued guidance range of $283.0 million to $303.0 million and falling well below the analyst consensus estimate of approximately $293.4 million.

The miss extended to profitability metrics as well. Preliminary non-GAAP operating margin was between 3.5% and 4.0%, significantly below the guided range of 5.0% to 9.0%. On a GAAP basis, the operating margin was expected to be negative, between (3.2)% and (4.0)%. Non-GAAP diluted earnings per share were projected at just $0.03 to $0.05, a fraction of the $0.13 analyst consensus. GAAP loss per share was expected between $(0.12) and $(0.14).

Customer-Specific Project Delay and Cost Pressures

Chairman and CEO Tom Stanton attributed the shortfall to two specific factors. First, a project delay from a single customer materially impacted the quarterly revenue line. Second, the company continues to navigate an elevated component and freight cost environment, which compressed margins more than anticipated. Stanton noted that, outside of this isolated customer dynamic, the company's optical networking business continues to perform well, and the innovation pipeline remains robust. Still, investors reacted swiftly to the magnitude of the miss, punishing the stock.

Soft Q3 Guidance Compounds the Gloom

Adding to the negative sentiment, ADTRAN also issued third-quarter 2026 guidance alongside the preliminary results. The company expects Q3 revenue between $275.0 million and $295.0 million, with non-GAAP operating margin in the range of 1.5% to 5.5%. At the midpoint, these figures suggest sequential revenue deterioration and further margin compression, signaling that the headwinds from customer project timing and elevated input costs are likely to persist into the current quarter. The weak forward outlook removed any hope of a quick recovery narrative.

Market Context and Trading Activity

The severity of Wednesday's move reflects the cumulative pressure that had already been building in ADTN shares. The stock has been in a sustained downtrend, falling from a 52-week high of $19.98 reached in late May 2026 to levels below $11.00 in recent weeks. Over the past month alone, ADTN had already lost more than 23% of its value even before Wednesday's plunge. Trading volume was significantly elevated, with pre-market and early-session activity far exceeding the typical daily average of roughly 1.4 million shares, reflecting deep investor concern and active repositioning.

The communications equipment sector has faced a mixed backdrop in 2026, with ongoing supply chain normalization and uneven carrier spending patterns creating volatility for component and solution providers. ADTRAN's miss, while partly company-specific, resonates with broader themes of customer caution and input-cost stickiness that have weighed on peer valuations as well.

Trending AI Robots

For investors seeking data-driven approaches to navigate volatile market conditions, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots actively deployed across thousands of tickers. Tickeron features hundreds of algorithmic trading bots, but only those demonstrating superior performance under current market conditions earn a spot in the Trending AI Robots section. These bots vary by trading strategy, timeframe, performance metrics, and traded symbols, allowing users to observe which automated approaches are currently aligned with shifting market dynamics. Explore the Trending AI Robots page to discover which AI-driven strategies are excelling in today's markets.

What Comes Next for ADTN

The immediate focus for ADTN shareholders and analysts shifts to the company's final Q2 2026 earnings release, scheduled for after the market close on Monday, August 3, 2026, followed by a conference call on Tuesday, August 4. Investors will be listening closely for additional color on the customer project delay — specifically whether revenue recognition is merely deferred into future quarters or represents a lost opportunity. The call will also provide an opportunity to evaluate management's strategy for mitigating component and freight cost pressures.

On the analyst front, Wall Street remains cautiously constructive with an average rating of Moderate Buy and a consensus price target of $18.00 according to recent data, though these targets were established before the preliminary results and may face downward revisions in the days ahead. Key risks include further customer concentration issues, prolonged margin compression, and the possibility that carrier spending patterns remain subdued through the second half of 2026. With the full quarterly report still nearly two weeks away, the stock may remain under pressure as the market digests the preliminary figures and reassesses the company's near-term trajectory.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ADTN

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ADTN in upward trend: price may jump up because it broke its lower Bollinger Band on September 28, 2026

ADTN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 44 cases where ADTN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ADTN's RSI Oscillator exited the oversold zone, 21 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 58 cases where ADTN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

Following a +1.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADTN advanced for three days, in 218 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADTN as a result. In 79 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADTN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for ADTN entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. ADTN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.279) is normal, around the industry mean (5.894). ADTN's P/E Ratio (500.000) is considerably higher than the industry average of (107.419). Projected Growth (PEG Ratio) (0.460) is also within normal values, averaging (0.778). Dividend Yield (0.015) settles around the average of (0.006) among similar stocks. P/S Ratio (0.501) is also within normal values, averaging (11.937).

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADTN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are Cisco Systems (NASDAQ:CSCO), Hewlett Packard Enterprise Company (NYSE:HPE), Lumentum Holdings (NASDAQ:LITE), Nokia Corp (NYSE:NOK), Ciena Corp (NYSE:CIEN), Ericsson (NASDAQ:ERIC).

Industry description

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

Market Cap

The average market capitalization across the Telecommunications Equipment Industry is 19.96B. The market cap for tickers in the group ranges from 3.88K to 420.83B. CSCO holds the highest valuation in this group at 420.83B. The lowest valued company is DZSI at 3.88K.

High and low price notable news

The average weekly price growth across all stocks in the Telecommunications Equipment Industry was 2%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 6%. INSG experienced the highest price growth at 28%, while CLRO experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Telecommunications Equipment Industry was -24%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 56
Price Growth Rating: 52
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
ADTN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of network access solutions

Industry TelecommunicationsEquipment

Industry
Telecommunications Equipment
Address
901 Explorer Boulevard
Phone
+1 256 963-8000
Employees
3338
Web
https://www.adtran.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.